Immune regulation in tumor-bearing hosts

This publication has 36 references indexed in Scilit:

• Enhancement of vaccine-mediated antitumor immunity in cancer patients after depletion of regulatory T cells
  Journal of Clinical Investigation, 2005
• Toll-Like Receptor 8-Mediated Reversal of CD4 ⁺ Regulatory T Cell Function
  Science, 2005
• CD4⁺CD25⁺FOXP3⁺ regulatory T cells from human thymus and cord blood suppress antigen‐specific T cell responses
  Immunology, 2005
• Inhibition of CD4+25+ T regulatory cell function implicated in enhanced immune response by low-dose cyclophosphamide
  Blood, 2005
• Definition of target antigens for naturally occurring CD4+ CD25+ regulatory T cells
  The Journal of Experimental Medicine, 2005
• Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25+CD4+ Tr cells
  Blood, 2005
• Human CD4+CD25+ regulatory T cells
  Seminars in Immunology, 2004
• CD4⁺CD25⁺ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative
  European Journal of Immunology, 2004
• Lymphocyte composition of tumor draining lymph nodes from cervical and endometrial cancer patients
  Gynecologic Oncology, 2004
• Control of Regulatory T Cell Development by the Transcription Factor Foxp3
  Science, 2003